Kidney disease affects millions of people in the United States. According to the National Kidney Foundation, about 1 in 7 American adults may have chronic kidney disease (CKD), though many don't know it. The kidneys are fist-sized organs that filter waste and extra water from your blood to make urine. When kidneys don't work as well as they should, waste builds up in your body and can cause serious health problems.
Learn About TV Connection Options →
Kidney disease often develops slowly without obvious symptoms in early stages. Many people discover they have it during routine blood work or urine tests. The disease is classified into five stages, with stage 1 being mild and stage 5 being kidney failure requiring dialysis or transplant. At each stage, different medications become important for slowing disease progression and managing complications.
The main goals of kidney disease treatment are to slow or stop the disease from getting worse, prevent related health problems like heart disease and high blood pressure, and reduce symptoms. Medications play a central role in achieving these goals. They work in different ways—some control blood pressure, others reduce protein in urine, and still others manage problems like anemia or bone disease that develop when kidneys aren't working properly.
Understanding which medications are used and why helps you work better with your healthcare team. Many people with kidney disease take multiple medications because the condition often affects different body systems at once. Your nephrologist (kidney specialist) or primary care doctor will recommend specific medications based on your stage of disease, blood pressure, other health conditions, and test results.
Practical Takeaway: Ask your doctor to explain your kidney disease stage and what your target numbers are for blood pressure, protein levels, and kidney function. Knowing these numbers helps you understand why each medication has been prescribed and track your progress over time.
Managing blood pressure is one of the most important parts of kidney disease treatment. High blood pressure both causes kidney damage and results from it, creating a cycle that can speed up disease progression. The American Heart Association recommends that people with kidney disease keep their blood pressure below 120/80 mmHg, which is lower than the general population target. Two types of blood pressure medications are especially valuable for kidney patients: ACE inhibitors and ARBs (angiotensin II receptor blockers).
Free Guide to Dental Implant Cost Options in McKinney →
ACE inhibitors include medications like lisinopril, enalapril, and ramipril. ARBs include losartan, valsartan, and irbesartan. These medications do more than just lower blood pressure—they also reduce protein loss through the kidneys and slow kidney damage progression. Studies show that people with kidney disease who take these medications have better outcomes than those on other blood pressure drugs alone. These are typically the first-choice medications for kidney disease patients with high blood pressure.
Other blood pressure medications may be added if ACE inhibitors or ARBs alone don't reach your target. Calcium channel blockers like amlodipine relax blood vessel walls. Diuretics like furosemide help your body remove extra fluid and salt, which reduces blood pressure. Beta-blockers like metoprolol slow your heart rate and reduce how hard your heart works. Each medication works differently, and your doctor may combine several types to reach your blood pressure goal.
Side effects vary by medication. ACE inhibitors and ARBs can cause a dry cough in some people and may temporarily raise potassium levels. Diuretics can lower potassium, which creates a different concern. Calcium channel blockers may cause swelling in your ankles or constipation. It's important to report any side effects because they may be manageable with dose adjustments or switching to a similar medication that works better for you personally.
Practical Takeaway: Check your blood pressure at home regularly using a validated monitor and keep a log. Bring these readings to your appointments so your doctor can see how well your medications are working and make adjustments if needed. Most pharmacies offer free blood pressure checks if you don't have a home monitor.
Anemia (low red blood cell count) develops in many people with kidney disease because kidneys produce less erythropoietin (EPO), a hormone that tells your bone marrow to make red blood cells. When red blood cells are low, your body doesn't carry oxygen as efficiently, causing fatigue, shortness of breath, dizziness, and difficulty concentrating. About 1 in 3 people with chronic kidney disease develop anemia. Treatment depends on the cause and severity.
Free Guide to Growing Peppercorns at Home →
Erythropoiesis-stimulating agents (ESAs) are synthetic versions of EPO that boost red blood cell production. Common ESAs include epoetin alfa (Procrit, Epogen) and darbepoetin alfa (Aranesp). These medications are typically given by injection, either under the skin or into a vein, usually once or twice weekly or every two weeks depending on the type and your response. ESAs can significantly reduce fatigue and improve quality of life, but they must be used carefully because too many red blood cells can increase blood clot risk and heart problems.
Iron supplements are often necessary alongside ESAs because your bone marrow needs iron to make new red blood cells. Iron can be taken by mouth as ferrous sulfate or ferrous gluconate, though many people with kidney disease don't absorb oral iron well. Intravenous iron—given directly into a vein—works better for many kidney patients. Types include iron sucrose, iron dextran, and ferric carboxymaltose. Your doctor will check iron levels regularly with blood tests and adjust supplements accordingly.
Newer medications called hypoxia-inducible factor (HIF) stabilizers, such as roxadustat and daprodustat, represent a different approach. These oral medications work by signaling your body to produce more of its own EPO rather than replacing it artificially. They may offer benefits for some patients, though they're newer and less widely used than ESAs and iron supplements.
Practical Takeaway: If you're prescribed ESAs or iron, keep your lab appointments so your doctor can monitor your hemoglobin, hematocrit, and iron levels. Report fatigue that worsens or doesn't improve to your care team, as this may mean your anemia medication needs adjustment.
Chronic kidney disease causes bone and mineral disease because kidneys regulate calcium, phosphorus, and vitamin D levels. When kidney function declines, phosphorus builds up in your blood and calcium drops. Your body responds by producing more parathyroid hormone (PTH), which pulls calcium from your bones. Over time, bones become weak and can break easily. Additionally, calcium can deposit in blood vessels and soft tissues, increasing heart disease risk. About 9 out of 10 people with advanced kidney disease develop bone and mineral disease.
Learn About Grants Motor Vehicle Division Services →
Phosphate binders are medications that trap phosphorus from food in your digestive system so it leaves your body in stool instead of being absorbed into your blood. Calcium-based binders like calcium acetate and calcium carbonate were historically common, but doctors now prefer non-calcium binders because excess calcium from these medications can contribute to vessel calcification. Non-calcium binders include sevelamer (Renagel, Renvela), lanthanum carbonate (Fosrenol), and newer options like patiromer (Patiromer) and sodium zirconium cyclosilicate (Lokelma).
Vitamin D supplements help maintain calcium levels and regulate PTH. Since kidney disease impairs vitamin D activation, kidney patients need special forms like calcitriol (Rocaltrol), which is already activated and doesn't require kidney processing. Your doctor monitors PTH and calcium levels to determine the right vitamin D dose, as too much can dangerously elevate calcium.
Calcimimetic medications like cinacalcet (Sensipar) and etelcalcetide (Parsabiv) work differently by making parathyroid glands less sensitive to calcium, causing them to produce less PTH. These are especially useful for people with secondary hyperparathyroidism (high PTH levels) that doesn't respond adequately to vitamin D and binders. They help prevent the bone and vessel problems caused by excess PTH.
Practical Takeaway: Take phosphate binders exactly as directed with meals, as timing matters for their effectiveness. Work with a renal dietitian to learn
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.